SIHUAN PHARM (00460): Che Yuxuan has been appointed as a non-executive director and a member of the board's risk management committee.

12:09 26/08/2026

Sihuan Pharmaceutical (00460) announced that due to focusing on her personal career development, Ms. Miao Guili has resigned as the company's executive director, vice president, and chief financial officer, and will no longer serve as co-chair of the board's risk management committee, effective from August 26, 2026.

SIHUAN PHARM (00460) announced that Ms. Miao Guili has resigned from her positions as executive director, deputy chief executive officer, and chief financial officer of the company due to a focus on personal career development. She will also no longer serve as co-chair of the boards risk management committee, effective August 26, 2026. Mr. Che Yuxuan has been appointed as a non-executive director of the company and a member of the boards risk management committee, effective August 26, 2026. Ms. Song Xiaomi has been appointed as the companys chief financial officer, effective August 26, 2026.

GIORDANO INT'L (00709) announced its interim results, with a profit attributable to shareholders of HKD 108 million, a year-on-year decrease of 10.74%. It plans to distribute an interim dividend of HKD 0.067 per share.

CG SERVICES (06098) announced its interim results, with a profit attributable to shareholders of approximately 950 million yuan, a decrease of 4.6% compared to the same period last year.

GIORDANO INT'L (00709) will distribute a mid-term dividend of HKD 0.067 per share on October 2.

CG SERVICES (06098) announced its interim results, with a profit attributable to shareholders of approximately 950 million yuan, a decrease of 4.6% compared to the same period last year.

GIORDANO INT'L (00709) will distribute a mid-term dividend of HKD 0.067 per share on October 2.